APLS Q1 2019 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$49M

Operating Income

-$49M

Net Income

-$51M

EPS (Diluted)

$-0.87

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$318M

Total Liabilities

$94M

Stockholders' Equity

$225M

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$49M	-$21M	-126.9%
Operating Income	-$49M	-$21M	-126.9%
Net Income	-$51M	-$22M	-132.7%